Newsfeeds Archive - Spark Newswire

3 minute read

Mostly Tricks, Few Treats For Pot Stocks in 2022

October 30, 8:58 PM

Halloween is prime spooky season, but for most investors, all of 2022 has been quite scary. Stocks across the board have taken substantial hits this year, with cannabis particularly affected. Cannabis' surging pandemic performances have been dashed mostly. Now, Fed uncertainty looms while profitability continues to elude most operators, from MSOs to the ancillary market.

ACB

4 minute read

Do Any States Face The Risk Of A Dominant Cannabis Market Operator?

By Andrew Ward

October 12, 8:43 AM

Is the American cannabis sector facing the prospect of just a few players dominating the market? While worries abound in some corners of the space, sources say that is not the current case.

CRLBF

4 minute read

Germany’s Adult Use Cannabis Laws Steeped In Optimism And Uncertainty At The Moment

By Andrew Ward

September 21, 11:22 AM

Luxembourg and Malta became the first two European nations to pass adult use can

IMCC

4 minute read

EXCLUSIVE – Why Wrestler Rob Van Dam Became A Cannabis Advocate, Patient And Entrepreneur: ‘I’m Glad To Help Spread The Education’

By Andrew Ward

August 21, 10:04 AM

Rob Van Dam is a modern-day legend in professional wrestling and cannabis advocacy. He's regarded as one of wrestling's innovators, normalizing death-defying dives combined with martial arts.

WWE

4 minute read

RICO Charges: Once Reserved For The Mafia Now A Familiar Anti-Cannabis Industry Tactic

By Andrew Ward

August 15, 11:45 AM

Charges stemming from the Racketeer Influenced and Corrupt Organizations (RICO) Act have long been a looming threat in the cannabis industry. Coming from civil, state and federal levels, the charges have been used as a method to stymie cannabis operations, whether just or not.

BILZF

4 minute read

With Trademark Infringement A Common Issue In Cannabis, Are Cease And Desist Orders Effective?

By Andrew Ward

August 12, 11:59 AM

Cease and desist (C&D) orders are relatively common in business. The nascent cannabis market is no exception. As the weed space steps into the legal mainstream market, its operators contend with various C&D orders from companies and regulators.

BILZF

4 minute read

Psychedelic Treatments Vary Greatly By Cost And Setting, What About Efficacy?

By Andrew Ward

August 10, 9:49 AM

Psychedelic therapy is on the rise. June 2022 data from Data Bridge Market Research reports that the US psychedelic drug market could be valued at $9.8 billion by 2029, with a nearly 17% CAGR.

GOOGL